Vassilis Karageorgiou
Tufts University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Vassilis Karageorgiou.
Biomaterials | 2004
Hyoung-Joon Jin; Jingsong Chen; Vassilis Karageorgiou; Gregory H. Altman; David L. Kaplan
Fibers with nanoscale diameters provide benefits due to high surface area for biomaterial scaffolds. In this study electrospun silk fibroin-based fibers with average diameter 700+/-50 nm were prepared from aqueous regenerated silkworm silk solutions. Adhesion, spreading and proliferation of human bone marrow stromal cells (BMSCs) on these silk matrices was studied. Scanning electron microscopy (SEM) and MTT analyses demonstrated that the electrospun silk matrices supported BMSC attachment and proliferation over 14 days in culture similar to native silk fibroin (approximately 15 microm fiber diameter) matrices. The ability of electrospun silk matrices to support BMSC attachment, spreading and growth in vitro, combined with a biocompatibility and biodegradable properties of the silk protein matrix, suggest potential use of these biomaterial matrices as scaffolds for tissue engineering.
Annals of Biomedical Engineering | 2004
Lorenz Meinel; Vassilis Karageorgiou; Robert Fajardo; Brian D. Snyder; Vivek R. Shinde-Patil; Ludwig Zichner; David L. Kaplan; Robert Langer; Gordana Vunjak-Novakovic
We report studies of bone tissue engineering using human mesenchymal stem cells (MSCs), a protein substrate (film or scaffold; fast degrading unmodified collagen, or slowly degrading cross-linked collagen and silk), and a bioreactor (static culture, spinner flask, or perfused cartridge). MSCs were isolated from human bone marrow, characterized for the expression of cell surface markers and the ability to undergo chondrogenesis and osteogenesis in vitro, and cultured for 5 weeks. MSCs were positive for CD105/endoglin, and had a potential for chondrogenic and osteogenic differentiation. In static culture, calcium deposition was similar for MSC grown on collagen scaffolds and films. Under medium flow, MSC on collagen scaffolds deposited more calcium and had a higher alcaline phosphatase (AP) activity than MSC on collagen films. The amounts of DNA were markedly higher in constructs based on slowly degrading (modified collagen and silk) scaffolds than on fast degrading (unmodified collagen) scaffolds. In spinner flasks, medium flow around constructs resulted in the formation of bone rods within the peripheral region, that were interconnected and perpendicular to the construct surface, whereas in perfused constructs, individual bone rods oriented in the direction of fluid flow formed throughout the construct volume. These results suggest that osteogenesis in cultured MSC can be modulated by scaffold properties and flow environment.
Biomaterials | 2003
Bruce Panilaitis; Gregory H. Altman; Jingsong Chen; Hyoung-Joon Jin; Vassilis Karageorgiou; David L. Kaplan
Silk fibers have potential biomedical applications beyond their traditional use as sutures. The physical properties of silk fibers and films make it a promising candidate for tissue engineering scaffold applications, particularly where high mechanical loads or tensile forces are applied or in cases where low rates of degradation are desirable. A critical issue for biomaterial scaffolds is biocompatibility. The direct inflammatory potential of intact silk fibers as well as extracts was studied in an in vitro system. The results indicate that silk fibers are largely immunologically inert in short- and long-term culture with RAW 264.7 murine macrophage cells while insoluble fibroin particles induced significant TNF release. Soluble sericin proteins extracted from native silk fibers did not induce significant macrophage activation. While sericin did not activate macrophages by itself, it demonstrated a synergistic effect with bacterial lipopolysaccharide. The low level of inflammatory potential of silk fibers makes them promising candidates in future biomedical applications.
Clinical Orthopaedics and Related Research | 2006
T. Kardestuncer; Mary Beth McCarthy; Vassilis Karageorgiou; David L. Kaplan; Gloria Gronowicz
Tendon reconstruction surgery often requires healing of the tendon to bone. The development of a more rapid and strong interaction at the tendon to bone interface would be invaluable to patients having orthopaedic surgery. Therefore, our rationale was to modify sutures so that they would be anabolic for tendon to bone healing. It has been shown that silk stimulates bone formation in osteoblast cultures. In the current study, we tested the ability of silk and silk-RGD (arginine-glycine-aspartic acid) to stimulate human tenocyte adhesion, proliferation, and differentiation. A 1.3-fold increase in tenocyte adhesion was found on silk-RGD compared with tissue culture plastic. By 72 hours, proliferation had increased on all substrates but was particularly enhanced on silk-RGD compared with the control. At 6 weeks, Northern blot analysis of decorin and Type I collagen mRNA levels showed a 2-3-fold increase in message levels on silk-RGD and silk compared with tissue culture plastic. The data suggest cultured human tenocytes adhere, proliferate, and differentiate on silk and silk-RGD substrates. A suture material, such as silk, decorated with RGD, may have the potential to facilitate tendon-bone healing with widespread applications in tendon reconstruction surgery.
Biomaterials | 2005
Vassilis Karageorgiou; David L. Kaplan
Biomaterials | 2005
Lorenz Meinel; Sandra Hofmann; Vassilis Karageorgiou; Carl A. Kirker-Head; John McCool; Gloria Gronowicz; Ludwig Zichner; Robert Langer; Gordana Vunjak-Novakovic; David L. Kaplan
Advanced Functional Materials | 2005
Hyoung-Joon Jin; Jaehyung Park; Vassilis Karageorgiou; Ung-Jin Kim; Regina Valluzzi; Peggy Cebe; David L. Kaplan
Journal of Biomedical Materials Research Part A | 2004
Lorenz Meinel; Vassilis Karageorgiou; Sandra Hofmann; Roberto J. Fajardo; Brian D. Snyder; Chunmei Li; Ludwig Zichner; Robert Langer; Gordana Vunjak-Novakovic; David L. Kaplan
Journal of Biomedical Materials Research Part A | 2003
Jingsong Chen; Gregory H. Altman; Vassilis Karageorgiou; Rebecca L. Horan; Adam L. Collette; Vladimir Volloch; David L. Kaplan
Biotechnology and Bioengineering | 2004
Lorenz Meinel; Sandra Hofmann; Vassilis Karageorgiou; Ludwig Zichner; Robert Langer; David L. Kaplan; Gordana Vunjak-Novakovic
Collaboration
Dive into the Vassilis Karageorgiou's collaboration.
University of Texas Health Science Center at San Antonio
View shared research outputs